Hepatitis C Treatment Access

 
 
Share this
 
 

NVHR believes that all people deserve access to treatment for hepatitis C. One of our top priorities is ensuring that public and private payers end all restrictions to treatment access.

On October 23, 2017, NVHR and the Center for Health Law and Policy Innovation of Harvard Law School released Hepatitis C: The State of Medicaid Access. This report details hepatitis C treatment restrictions in all state Medicaid programs, including traditional fee-for-service as well as managed care. The report focuses on three of the most significant restrictions to treatment: liver damage, sobriety, and prescriber limitations. It is the most comprehensive public listing of these restrictions to date.

We also released report cards for each state Medicaid program (including District of Columbia and Puerto Rico). These report cards provide a grade for each state based on their restrictions and include recommendations for improving access for hepatitis C patients. Report cards will be updated as states change their Medicaid policies.

You can read the report and report cards at www.stateofhepc.org

In May 2018, NVHR submitted a sign-on letter in support of access to HCV treatment for Medicaid beneficiaries. We collected over 100 signatures. You can view it here.

 

October 2019

Hepatitis C Treatment Access Sign-on Letter

Please join the National Viral Hepatitis Roundtable and the Center for Health Law and Policy Innovation at Harvard University to urge the Centers for Medicare and Medicaid Services to address illegal hepatitis C treatment prior authorization criteria in state Medicaid programs. Add your name!

Read the Sign-on Letter to CMS

 

Press Releases:

Press Release: NVHR and CHLPI 

WASHINGTON, DC & BOSTON, MA (Oct. 10, 2019) – The National Viral Hepatitis Roundtable (NVHR) and the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) today launched an update to “Hepatitis C: State of Medicaid Access,” an interactive project grading all 50 state Medicaid programs, as well as the District of Columbia and Puerto Rico, according to access to curative treatments for hepatitis C, the nation’s deadliest infectious disease. NVHR, Harvard and other leading viral hepatitis advocates today also sent a letter to the U.S. Centers for Medicare and Medicaid Services (CMS) urging the agency to take action to end discriminatory state treatment restrictions, which, according to CMS guidance, violate federal Medicaid law. 

 

Harvard Law School & NVHR Launch Interactive Report Card Project Grading 52 Medicaid Programs for Discriminatory Hepatitis C Treatment Restrictions

Louisiana Receives ‘F’ in New Harvard Law School & NVHR Report Card Project Grading Medicaid Programs for Discriminatory Hepatitis C Treatment Restrictions

Montana Receives ‘F’ in New Harvard Law School & NVHR Report Card Project Grading Medicaid Programs for Discriminatory Hepatitis C Treatment Restrictions

If you are interested in staying connected with NVHR, please join our listserv. We send out information about policy calls, program updates, webinars, and more. If you would like to join a listserv for community members to discuss hepatitis C treatment access advocacy strategies, email info@nvhr.org